IGC Pharma (IGC) EBITDA Margin (2010 - 2026)
IGC Pharma (IGC) recorded EBITDA Margin of -757.10% in FY2026, down 219.88 percentage points from -537.21% in FY2025.
Powered by 
Analysis
IGC Pharma (IGC) EBITDA Margin (2010 - 2026) Analysis & Trends
Starting with FY2011, IGC Pharma's EBITDA Margin history includes 16 years.
- Annual EBITDA Margin has a five-year change of +161.17 percentage points (FY2021 to FY2026).
- The FY2026 figure is the lowest annual EBITDA Margin since FY2023.
- Per Business Quant data, IGC's EBITDA Margin was -537.21% in FY2025 (+143.90 pp), -681.12% in FY2024 (+516.91 pp), -1198.02% in FY2023 (+2524.14 pp) and -3722.17% in FY2022 (-2803.90 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | IGC Pharma | 24.10 Mn | 21.34 Mn | 55,000.00 | -757.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -757.10% |
| Sep 30, 2025 | -1,455.50% |
| Jun 30, 2025 | -537.80% |
| Mar 31, 2025 | -381.52% |
| Dec 31, 2024 | -669.65% |
| Sep 30, 2024 | -391.99% |
| Jun 30, 2024 | -821.32% |
| Mar 31, 2024 | -680.00% |
| Dec 31, 2023 | -1,391.18% |
| Sep 30, 2023 | -801.72% |
| Jun 30, 2023 | -357.48% |
| Mar 31, 2023 | -2,340.96% |
| Dec 31, 2022 | -634.34% |
| Sep 30, 2022 | -1,147.52% |
| Jun 30, 2022 | -1,245.28% |
| Mar 31, 2022 | -5,193.44% |
| Dec 31, 2021 | -1,562.68% |
| Sep 30, 2021 | -7,473.21% |
| Jun 30, 2021 | -2,645.45% |
| Mar 31, 2021 | -3,240.74% |
API Access
IGC Pharma EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();